Graham Capital Management, L.P. Ab Cellera Biologics Inc. Transaction History

Graham Capital Management, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.29 - $5.97 $118,429 - $164,807	-27,606 Reduced 36.73%	47,551 $215,000
Q4 2023 Feb 14, 2024	SELL	$3.91 - $5.93 $411,457 - $624,025	-105,232 Reduced 58.34%	75,157 $429,000
Q3 2023 Nov 22, 2023	BUY	$4.6 - $7.95 $497,075 - $859,077	108,060 Added 149.4%	180,389 $829,000
Q2 2023 Aug 14, 2023	SELL	$5.66 - $7.59 $2.27 Million - $3.05 Million	-401,921 Reduced 84.75%	72,329 $467,000
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $2.38 Million - $3.63 Million	325,051 Added 217.86%	474,250 $3.58 Million
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $2.42 Million - $3.7 Million	-254,972 Reduced 63.09%	149,199 $1.51 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $3.13 Million - $4.66 Million	340,732 Added 537.1%	404,171 $4 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $362,871 - $675,625	63,439 New	63,439 $675,000
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $191,923 - $363,779	-25,727 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $334,193 - $456,139	25,727 New	25,727 $367,000

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $833M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.